➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Mallinckrodt
Medtronic
Baxter
Dow

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PLATINOL-AQ

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Platinol-aq

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002735 ↗ SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue Terminated National Cancer Institute (NCI) Phase 2 1996-04-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating patients with stage III or stage IV cancer of the hypopharynx or tongue.
NCT00002735 ↗ SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue Terminated Southwest Oncology Group Phase 2 1996-04-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and radiation therapy in treating patients with stage III or stage IV cancer of the hypopharynx or tongue.
NCT00002835 ↗ Combination Chemotherapy in Treating Patients With Lymphoma Completed National Cancer Institute (NCI) Phase 3 1995-07-01 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of combination chemotherapy in treating patients who have intermediate-grade or immunoblastic lymphoma.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Platinol-aq

Condition Name

Condition Name for Platinol-aq
Intervention Trials
Stage IIIA Lung Cancer AJCC v8 7
Stage III Lung Cancer AJCC v8 5
Stage IIIC Lung Cancer AJCC v8 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Platinol-aq
Intervention Trials
Carcinoma 34
Lung Neoplasms 21
Carcinoma, Squamous Cell 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Platinol-aq

Trials by Country

Trials by Country for Platinol-aq
Location Trials
United States 155
Argentina 5
Canada 4
China 4
Belgium 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Platinol-aq
Location Trials
Texas 19
California 11
Minnesota 8
Pennsylvania 8
New York 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Platinol-aq

Clinical Trial Phase

Clinical Trial Phase for Platinol-aq
Clinical Trial Phase Trials
Phase 3 18
Phase 2/Phase 3 7
Phase 2 46
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Platinol-aq
Clinical Trial Phase Trials
Not yet recruiting 59
Recruiting 18
Completed 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Platinol-aq

Sponsor Name

Sponsor Name for Platinol-aq
Sponsor Trials
National Cancer Institute (NCI) 50
M.D. Anderson Cancer Center 13
Bristol-Myers Squibb 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Platinol-aq
Sponsor Trials
Other 84
NIH 51
Industry 35
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
AstraZeneca
Boehringer Ingelheim
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.